Harmony Biosciences Holdings, Inc. (HRMY)

NGM – Real Time Price. Currency in USD

39.32

-0.20 (-0.51%)

Market open: Aug 12, 2026, 2:05 PM EDT

39.51

-0.01 (-0.03%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

868M

715M

582M

438M

Cost of goods sold

-222M

-181M

-145M

-106M

Gross Profit

646M

534M

437M

331M

Operating expenses (excl. COGS)

-438M

-343M

-245M

-211M

Operating Income

208M

191M

192M

120M

Non-operating income, total

978K

-19M

-16M

Pretax income

215M

192M

173M

105M

Equity in earnings

Taxes

-56M

-46M

-45M

77M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

159M

145M

129M

181M

Discontinued operations

Net income

159M

145M

129M

181M

Dilution adjustment

Preferred dividends

Harmony Biosciences Holdings, Inc. (HRMY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Harmony Biosciences Holdings, Inc. (HRMY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Harmony Biosciences Holdings, Inc. (HRMY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Harmony Biosciences Holdings, Inc. (HRMY)

Income Statement (Annual)

Income Statement (Annual)